全文获取类型
收费全文 | 4621篇 |
免费 | 239篇 |
出版年
2023年 | 27篇 |
2021年 | 94篇 |
2020年 | 55篇 |
2019年 | 75篇 |
2018年 | 85篇 |
2017年 | 89篇 |
2016年 | 110篇 |
2015年 | 160篇 |
2014年 | 193篇 |
2013年 | 254篇 |
2012年 | 345篇 |
2011年 | 291篇 |
2010年 | 215篇 |
2009年 | 170篇 |
2008年 | 226篇 |
2007年 | 200篇 |
2006年 | 165篇 |
2005年 | 183篇 |
2004年 | 163篇 |
2003年 | 119篇 |
2002年 | 128篇 |
2001年 | 98篇 |
2000年 | 68篇 |
1999年 | 81篇 |
1998年 | 33篇 |
1997年 | 35篇 |
1996年 | 31篇 |
1995年 | 29篇 |
1994年 | 33篇 |
1992年 | 57篇 |
1991年 | 64篇 |
1990年 | 50篇 |
1989年 | 59篇 |
1988年 | 42篇 |
1987年 | 49篇 |
1986年 | 33篇 |
1985年 | 73篇 |
1984年 | 47篇 |
1983年 | 52篇 |
1982年 | 29篇 |
1981年 | 35篇 |
1980年 | 46篇 |
1979年 | 56篇 |
1978年 | 34篇 |
1975年 | 29篇 |
1974年 | 33篇 |
1973年 | 28篇 |
1971年 | 34篇 |
1970年 | 30篇 |
1969年 | 33篇 |
排序方式: 共有4860条查询结果,搜索用时 640 毫秒
1.
Background
Substituted catechols are important precursors for large-scale synthesis of pharmaceuticals and other industrial products. Most of the reported chemical synthesis methods are expensive and insufficient at industrial level. However, biological processes for production of substituted catechols could be highly selective and suitable for industrial purposes. 相似文献2.
Shailesh Kumar Atma P. Dwivedi Vivek Kr. Kashyap A.K. Saxena A.K. Dwivedi Ranjana Srivastava Devi P. Sahu 《Bioorganic & medicinal chemistry letters》2013,23(8):2404-2407
Synthesis of a library of novel trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxy alkyl amines and their antimycobacterial activity against drug sensitive and multidrug resistant strains of Mycobacterium tuberculosis have been reported. All the new compounds in the series exhibited MIC between 1.56 and 6.25 μg/ml. Two compounds 1i and 1j with low MIC and low cytotoxicity showed significant reduction in CFU in infected mouse macrophages at 1× MIC concentration. The compound 1i inhibited the growth of M. tuberculosis in mice at 100 mg/kg dose with 1.35 log10 reduction of CFU in lungs tissue and was active against non-replicating Mycobacterium tuberculosis under anaerobic condition. 相似文献
3.
A C Srivastava A J Pinching M W Adler R Robertson R Higgs 《BMJ (Clinical research ed.)》1987,294(6570):495-496
Dr A C Srivastava has written to us to describe a case that raises the suggestion that people infected with the human immuno-deficiency virus (HIV) should carry identity cards. We asked two physicians, a general practitioner working with patients with the acquired immune deficiency syndrome (AIDS), and a general practitioner with a special interest in medical ethics to respond to the broad issues raised by Dr Srivastava''s letter. 相似文献
4.
5.
6.
Molecular and Cellular Biochemistry - 相似文献
7.
8.
9.
Emily Olfson Catherine E. Cottrell Nicholas O. Davidson Christina A. Gurnett Jonathan W. Heusel Nathan O. Stitziel Li-Shiun Chen Sarah Hartz Rakesh Nagarajan Nancy L. Saccone Laura J. Bierut 《PloS one》2015,10(9)
The American College of Medical Genetics and Genomics (ACMG) recommends that clinical sequencing laboratories return secondary findings in 56 genes associated with medically actionable conditions. Our goal was to apply a systematic, stringent approach consistent with clinical standards to estimate the prevalence of pathogenic variants associated with such conditions using a diverse sequencing reference sample. Candidate variants in the 56 ACMG genes were selected from Phase 1 of the 1000 Genomes dataset, which contains sequencing information on 1,092 unrelated individuals from across the world. These variants were filtered using the Human Gene Mutation Database (HGMD) Professional version and defined parameters, appraised through literature review, and examined by a clinical laboratory specialist and expert physician. Over 70,000 genetic variants were extracted from the 56 genes, and filtering identified 237 variants annotated as disease causing by HGMD Professional. Literature review and expert evaluation determined that 7 of these variants were pathogenic or likely pathogenic. Furthermore, 5 additional truncating variants not listed as disease causing in HGMD Professional were identified as likely pathogenic. These 12 secondary findings are associated with diseases that could inform medical follow-up, including cancer predisposition syndromes, cardiac conditions, and familial hypercholesterolemia. The majority of the identified medically actionable findings were in individuals from the European (5/379) and Americas (4/181) ancestry groups, with fewer findings in Asian (2/286) and African (1/246) ancestry groups. Our results suggest that medically relevant secondary findings can be identified in approximately 1% (12/1092) of individuals in a diverse reference sample. As clinical sequencing laboratories continue to implement the ACMG recommendations, our results highlight that at least a small number of potentially important secondary findings can be selected for return. Our results also confirm that understudied populations will not reap proportionate benefits of genomic medicine, highlighting the need for continued research efforts on genetic diseases in these populations. 相似文献
10.